• Follow the Money: Alpha-9 to Advance Radiopharmaceuticals, Dermatitis, Crohn’s Disease Studies, More

    Clinical Research News | Alpha-9 funds targeted radiopharmaceuticals; Evommune pursues chronic urticaria and atopic dermatitis; Agomab Therapeutics advances lead candidate in Crohn’s disease (FSCD); and more.

    Nov 26, 2024

  • GeneDX Novel Data Visualization Tool, New Landmark Parkinson’s Initiative, More

    Clinical Research News | GeneDx announced GeneDx Discover, a first-of-its-kind data visualization tool, which provides biopharmaceutical companies access to deidentified and aggregated genetic data—powered by GeneDx’s database—to improve all stages of drug development; Critical Path Institute announced a landmark initiative, Gender Equitable Medicines for Parkinson's Disease, dedicated to globally advancing actionable research on how Parkinson's disease uniquely impacts women and individuals across the sex and gender spectrum; and more.

    Nov 25, 2024

  • Trends in Biosimilars

    Clinical Research News | The global biosimilars market is experiencing substantial growth, valued at $29.45 billion in 2023, it is projected to reach $150.3 billion by 2033 (CAGR of 17.7%). This upward trajectory is primarily driven by the ability of biosimilars to offer safe, clinically effective, and cost-effective alternatives to reference biologics, expanding patient access to treatments for the ever-rising number of chronic and severe illnesses.

    Nov 22, 2024

  • AI Drug Repurposing Tool Offers Suggestions Based on Disease Networks

    Clinical Research News | arvard scientists, led by Dr. Marinka Zitnik, have developed an AI-based tool, TxGNN, to identify drug repurposing opportunities for diseases lacking effective treatments. The AI model harnesses a novel approach by focusing on multiple diseases simultaneously, allowing insights from well-documented conditions to be applied to rare diseases with sparse data.

    Nov 20, 2024

  • Pharma Leaders Tackle Persistent Quality Challenges and the Future of Clinical Trials

    Clinical Research News | Pharma leaders took on clinical trial quality in a panel discussion at the SCOPE Europe conference last month in Barcelona. While technologies change, the conversation underscored a central truth: the push for quality in clinical research remains as vital, yet as challenging, as ever.

    Nov 19, 2024